Arcus Biosciences, Inc. (RCUS)
15.62
-0.16
(-1.01%)
USD |
NYSE |
Nov 20, 16:00
15.64
+0.02
(+0.13%)
Pre-Market: 20:00
Arcus Biosciences Debt to Equity Ratio : 0.324 for Sept. 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2026 | 0.324 |
| June 30, 2026 | 0.2457 |
| March 31, 2026 | 0.2156 |
| December 31, 2025 | 0.3138 |
| September 30, 2025 | 0.2546 |
| June 30, 2025 | 0.1985 |
| March 31, 2025 | 0.113 |
| December 31, 2024 | 0.3278 |
| September 30, 2024 | 0.1027 |
| June 30, 2024 | 0.0173 |
| March 31, 2024 | 0.0156 |
| December 31, 2023 | 0.2619 |
| September 30, 2023 | 0.0173 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.1826 |
| September 30, 2022 | 0.1706 |
| June 30, 2022 | 0.1624 |
| Date | Value |
|---|---|
| March 31, 2022 | 0.1441 |
| December 31, 2021 | 0.145 |
| September 30, 2021 | 0.0902 |
| June 30, 2021 | 0.0823 |
| March 31, 2021 | 0.0221 |
| December 31, 2020 | 0.0361 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Halozyme Therapeutics, Inc. | -58.84 |
| AVITA Medical, Inc. | -1.519 |
| Iovance Biotherapeutics, Inc. | 0.0556 |
| Editas Medicine, Inc. | 0.8372 |
| Recursion Pharmaceuticals, Inc. | 0.0825 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 818.00M |
| Total Liabilities (Quarterly) | 460.00M |
| Shareholders Equity (Quarterly) | 358.00M |
| Current Ratio | 3.337 |
| Net Debt Paydown Yield | -0.04% |